Skip to main content
REGN
NASDAQ Life Sciences

Single-Dose CIDEB siRNA Cuts Liver Fat Up to 80% in MASLD, Published in NEJM

Tom Rudovsky · Reported by GlobeNewswire
More coverage: Biotech Stocks · Healthcare
Sentiment info
Positive
Importance info
7
Price
$900
Mkt Cap
$93.538B
52W Low
$591.52
52W High
$991.73
52W Position info
52% above low
Off High info
9.2% below high
Rel. Volume info
1.5× avg
Market data snapshot near publication time

REGN sits 52% above its 52-week low of $591.52.

Summary

A single subcutaneous dose of Regeneron's first-in-class CIDEB siRNA cut liver fat by 58-80% at week 36 in a Phase 1/2 MASLD trial, with 62% of treated patients normalizing liver fat versus none on placebo. The data were simultaneously published in the New England Journal of Medicine and presented orally at AASLD, a strong validation signal for a program Regeneron built from its own genetics center discovery. Depth of fat reduction beats the 47-57% at roughly one year reported for currently approved MASH therapies, and the clean tolerability profile with no nausea or vomiting addresses a key limitation of rivals. This is early-stage — Phase 2a, 2b and Phase 3 trials are only now recruiting — so revenue is years away, but it materially strengthens the cardiometabolic pipeline story alongside the recent Sanofi immunology expansion. Regeneron hosts a virtual roundtable on its MASH programs November 10 at 8:30 a.m. ET.

At the time of this announcement, REGN was trading at $900.00 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $93.5B. The 52-week trading range was $591.52 to $991.73. This news item was assessed with positive market sentiment and an importance score of 7 out of 10. Source: GlobeNewswire.


Price Chart

Share this article

Copied!

REGN - Latest Insights

REGN
Oct 30, 2026, 12:34 PM EDT
Source: Benzinga
Importance Score:
7
Price at Filing: $910.52
Real-time Price: $900.00 info
Change: -$10.52 (-1%) info
Market Cap: $93.538B info
REGN
Oct 30, 2026, 6:50 AM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $856.00
Real-time Price: $900.00 info
Change: +$44.00 (+5%) info
Market Cap: $93.538B info
REGN
Oct 30, 2026, 6:30 AM EDT
Source: Dow Jones Newswires
Importance Score:
8
Price at Filing: $835.00
Real-time Price: $900.00 info
Change: +$65.00 (+8%) info
Market Cap: $93.538B info
REGN
Oct 12, 2026, 12:06 PM EDT
Source: GlobeNewswire
Importance Score:
8
Price at Filing: $764.45
Real-time Price: $900.00 info
Change: +$135.55 (+18%) info
Market Cap: $93.538B info
REGN
Oct 06, 2026, 7:51 AM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $721.96
Real-time Price: $900.00 info
Change: +$178.04 (+25%) info
Market Cap: $93.538B info